gastrointestinal stromal tumor Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (4)

Phase 1 (1)
Phase 1/2 (1)
Phase 2 (2)

Interventional (4)

CStone Pharmaceuticals (1)
Daiichi Sankyo, Inc. (1)
Maria Sklodowska-Curie Institute - Oncology Center (1)
Zai Lab (Shanghai) Co., Ltd. (1)

No (4)

No (4)

Adult (18+) (4)

I am/have/had

I am/have/hadgastrointestinal stromal tumor

I am/have/hadstromal tumor

I am/have/hadmeasurable disease

I am/have/hadPDGFRA

I am/have/hadcancer

I am/have/hadcardiovascular disease

I am/have/hadhypertension

I am/have/hadmetastasis

I am/have/hadtyrosine

I am/have/hadmetastatic gastrointestinal stromal tumor

I am/have/hadpdgfra d842v

I am/have/hadneutrophil count

I am/have/hadcongestive heart failure

I am/have/hadstroke

I am/have/hadplatelet count

I am/have/hadmyocardial infarction

I am/have/hadmetastatic gastrointestinal stromal tumor (gist)

I am/have/hadgilbert's syndrome

I am/have/hadpdgfra d842v mutation

I am/have/hadcancer treatment

added new label for I am/have/had

I am looking for

I am looking forimatinib

I am looking forsunitinib

I am looking fortyrosine

I am looking foradjuvant

I am looking forkinase inhibitor

I am looking forgrowth factor

I am looking forchemotherapeutic agent

I am looking forripretinib

I am looking fordcc-2618

I am looking foranticoagulants

I am looking forblu-285

I am looking foraxitinib

I am looking foravelumab

I am looking forcombined oral contraceptives

added new label for I am looking for

Advanced Filters

Found 4 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

gastrointestinal stromal tumor

growth factor

minor surgery

immunohistochemistry

cancer

0 views
19 Feb, 2024

A Study of DCC-2618 (Ripretinib) Evaluating Efficacy Safety and Pharmacokinetics In Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

The primary objective of this trial is to evaluate the progress free survival (PFS) of DCC-2618 in patients with advanced gastrointestinal stromal tumors who have progressed with prior anticancer therapies based on independent radiologic review.This study will enroll approximately 35 subjects in up to 10 sites in China mainland, and …

gastrointestinal stromal tumor

stromal tumor

dcc-2618

measurable disease

ripretinib

0 views
19 Feb, 2024

A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

This study is an open-label, multicenter, phase I/II study to evaluate the safety, PK and clinical efficacy of avapritinib in Chinese subjects with unresectable or metastatic GIST. The study consists of two parts: dose escalation (phase I) and dose expansion (phase II).

gastrointestinal stromal tumor

pdgfra gene

stromal tumor

kinase inhibitor

adjuvant

0 views
19 Feb, 2024

A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy

To assess anti-tumor activity of avelumab in combination with axitinib in patients with unresectable/metastatic GIST after progression on second or third line treatment (after failure on at least of imatinib and sunitinib) in terms of progression-free survival (PFS)

gastrointestinal stromal tumor

cardiac arrhythmia

congestive heart failure

immunohistochemistry

glomerular filtration rate

0 views
19 Feb, 2024